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Synchronised neural oscillations preceding speech generation are reduced in patients with 
schizophrenia, this deficit being implicated in symptom formation. We measured synchronisation 
of neural oscillations preceding vocalisation in the presence of delta-9 tetrahydrocannabinol (THC) 
and found they were significantly disrupted. Furthermore, the degree of disruption was related to 
THC-induced symptoms, suggesting THC may modulate a similar neural substrate to schizophrenia. 
 
Self-generated actions are preceded by synchronised neural oscillations thought to be associated 
with preparation for movement.1, 2 These oscillations may be involved in forming an internal 
representation (efference copy) of the actions, allowing subsequent sensory inputs to be correctly 
identified as originating from the self.2, 3 This process may be impaired in patients with 
schizophrenia, leading to a failure to generate a sense of agency, and giving rise to delusions and 
hallucinations.3, 4. For example, patients with schizophrenia do not display the normal pattern of 
frontal neural oscillatory synchronisation (intertrial coherence [ITC]) in the 150ms preceding the 
onset of self-generated speech as measured by electroencephalography (EEG).2 This disruption of 
ITC, is related to auditory hallucinations.2 
 
Acute intravenous (IV) administration of delta-9 tetrahydrocannabinol (THC) – the main psychoactive 
component of cannabis – may induce perceptual disturbances some of which resemble positive 
symptoms of schizophrenia.5-7 Here, we test the hypothesis that IV THC administration disrupts ITC 
in the 150ms prior to the onset of self-generated vocalisation, over the same region of frontal cortex 
previously studied in patients with schizophrenia (EEG lead FCz) 2 and that the level of disruption is 
associated with the degree of THC-induced psychopathology. 
 
Methods are fully described in supplemental materials. We administered 1.25mg THC or placebo to 
16 healthy volunteers prior to a self-generated vocalisation task during EEG acquisition. Volunteers 
completed a self-rated 24-item questionnaire on cannabis effects before and 30 minutes after the 
infusion (see supplemental materials). THC led to a significant increase in self-rated measures of 
salience (t=2.69, df=15, p=0.01), ipseity disturbance (t = 2.73, df = 15, p=0.015), anxiety (t=2.50, 
df=15, p=0.02), paranoid persecutory ideation (t=2.97, df = 15, p=0.01) and perceptual abnormalities 
(t = 4.16, df = 15, p=0.0008). 
 
THC administration attenuated pre-speech ITC in the 150ms prior to the onset of self-generated 
speech, primarily at 3.9Hz, but also at 7.8Hz (3.9Hz: t =  4.78, df = 15, p=0.0002; 7.8Hz: t = 2.63, df = 
15, p=0.02, figure 1). The ITC reduction was specific to speech generation as there was no difference 
in ITC between THC and placebo conditions prior to the onset of the visual cue used in the task at 
frontal or occipital electrode sites. At 11.7Hz, THC led to a modest increase in ITC  (t = 2.29, df = 15. p 
= 0.04), and there was a trend for increase in ITC at 15.6Hz (t = 1.96, df = 15, p = 0.07). 
 
The degree of reduction in 3.9Hz ITC 150-0ms before onset of vocalisation was related to increasing 
self-rated measures of salience, simplifying to a single term - “my thoughts are more special or 
significant than usual” (F1,14 = 4.69, p=0.048). It was also related to increasing self-rated measures of 
ipseity disturbance, simplifying to a single term - “I believe my mind is being read” (F1,14 = 7.871, 
p=0.014). There was no relationship between ITC changes in any other frequency band with self-
rated measures of cannabis effects. 
 
These results provide the first evidence that THC disrupts ITC prior to the onset of self-generated 
vocalisation, and that the degree of disruption is related to THC-induced psychological effects. The 
findings show considerable overlap with previously reported data in patients with schizophrenia,2  
although the frequency changes reported here are in a lower frequency band. This may reflect the 
lower frequency resolution used in the schizophrenia study, where changes in theta and alpha range 
ITC would have contributed to the lowest resolvable frequency at 15.6 Hz. However, it is also 
possible the ITC pre-vocalisation changes in schizophrenia have a different frequency composition to 
those found under THC, pointing to a difference in efference processing dysfunction in the two 
conditions. Whether the effect of THC is the same or closely related to that found in schizophrenia, 
our findings indicate modulation of ITC by THC may be a useful biomarker for the development of 
novel antipsychotic drugs. 
Figure 1:  
Time-frequency analysis of ITC EEG data acquired from FCz prior to the onset of vocalisation (time 0) 
following IV injection of placebo (a) or delta-9 THC (b). 
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Methods 
The present study formed part of a series of experiments. Details of recruitment and demographics 
have been published elsewhere.1, 2 Sixteen healthy volunteers (26 +/- 5 yrs; 9 females) with previous 
exposure to cannabis received either intravenous THC (1.25mg) or placebo (normal saline) on two 
separate occasions in a randomised order.  
Symptoms were self-rated using a 5-domain, 24-item subjective effects of cannabis questionnaire 
(table 1), derived from the most commonly self-reported phenomena in 2 previous intravenous THC 
studies involving 32 individuals.3, 4 Ratings were taken at baseline and at 30 minutes post-injection 
(pi). 
  
At 15 minutes pi subjects vocalised the phoneme represented in English as “Aah” following the 
presentation of a visual cue (an X) on the computer screen, having previously been trained to 
vocalise with the minimum of jaw, tongue and throat movement. EEG data were acquired as 
previously reported,2 (Neuroscan system, 64 electrode cap, linked mastoid reference, ground at AFZ, 
sample rate 2000Hz, high pass filter 0.05Hz, low pass filter 200Hz). The data was divided into 900ms 
epochs, time-locked to the onset of each vocalisation (400ms before to 500ms after vocalisation) 
and baseline corrected (400 to 250ms before vocalisation). Vocalisation events were detected using 
in-house software that sent an event marker to the EEG amplifier when a predefined amplitude 
threshold was reached in the microphone input. To take into account the computational time 
required to process the auditory signal and send the event marker to the EEG amplifier, a delay was 
introduced such that the marker was sent 200 ms after the threshold was detected. Timings were 
adjusted in the subsequent offline analysis such that 0 ms corresponded to the onset of vocalisation. 
The influence of THC on the visually evoked ITC was examined using the same parameters but 
epoching the data in relation to the X cue instead of vocalisation.     
Analysis of inter-trial coherence (ITC) was performed using EEGLAB.5 ITC values were calculated 
using a fast Fourier transform window (256 ms wide without zero padding) moving across 200 time 
points (EEGLAB finds the closest time point for each increment with an average increment of 3.22 
ms). Note the time window used is of longer duration than that used in the Ford et al 2007 study (64 
ms) allowing resolution of theta and alpha frequencies. A Hanning window was applied to each 256 
ms window to reduce leakage from adjacent frequencies. ITC for each session was calculated for 4 
linearly spaced frequencies (3.9 Hz, 7.8 Hz, 11.7 Hz and 15.6 Hz) in the same electrode (FCz) studied 
by Ford et al.6 As in the Ford et al. study, ITC was examined in the 150ms prior to the speech onset 
(the time range believed to reflect efference copy generation).  Placebo and THC sessions were 
compared using paired t-tests and the relationship between subjective effects of cannabis grouped 
by symptom domain (table 1) and ITC reduction in the pre-speech period investigated using stepwise 
multiple regression. 
 
Table 1: Subjective Effects of Cannabis Questionnaire. All items are self-rated according to intensity 
on a scale of 0-5 (No, Minimal, Moderate, Strong, Extreme). The scale comprises 5 distinct 
phenomenological domains – salience (s), ipseity disturbance (id), anxiety (a), paranoid persecutory 
ideation (p) and perceptual disturbances (per). 
1 Currently I'm interested in objects in the environment, more than usual s 
2 This experience is frightening. a 
3 This feels like a set up. p 
4 My perception of time is altered. per 
5 My thoughts are more special or significant than usual. s 
6 My thoughts or movements seem to have a life of their own id 
7 I'm worried for my mental or physical health a 
8 I'm paranoid about the researchers p 
9 My perception of objects is altered. per 
10 I feel agitated a 
11 I'm experiencing profound insights s 
12 There is an unusual delay between my thinking and speaking. per 
13 I'm worried this state of mind won't end. a 
14 I believe I'm being made a fool of. p 
15 Sounds are distorted. per 
16 People are are saying things with 'hidden' or double meanings p 
17 I am unsure if I have just been thinking a thing or have actually said it out-loud. id 
18 I feel I'm making a fool of myself a 
19 I believe my mind is being read. id 
20 I (or others) can hear my inner thoughts outside in external space. per 
21 Currently, events are more significant than usual. s 
22 My thoughts or movements are being controlled by something or somebody else. id 
23 I feel threatened by the researchers. p 
24 My perception of my own body is altered. per 
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